| Product Code: ETC7227789 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
France`s import of pyruvate kinase saw a notable increase in concentration levels in 2024, shifting from low to moderate concentration. Key exporting countries including Denmark, Belgium, Netherlands, Germany, and Japan contributed significantly to this growth. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a robust 7.93%, indicating a steady upward trend. Moreover, the growth rate from 2023 to 2024 was recorded at 2.36%, reinforcing the positive momentum in the import market for pyruvate kinase in France.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Pyruvate Kinase Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Pyruvate Kinase Market Revenues & Volume, 2021 & 2031F |
3.3 France Pyruvate Kinase Market - Industry Life Cycle |
3.4 France Pyruvate Kinase Market - Porter's Five Forces |
3.5 France Pyruvate Kinase Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 France Pyruvate Kinase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pyruvate kinase deficiency in France |
4.2.2 Growing demand for advanced diagnostic tools for early detection of pyruvate kinase disorders |
4.2.3 Rise in awareness about the importance of early diagnosis and treatment of pyruvate kinase-related conditions |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of pyruvate kinase testing kits in France |
4.3.2 Limited availability of skilled healthcare professionals for conducting pyruvate kinase tests |
5 France Pyruvate Kinase Market Trends |
6 France Pyruvate Kinase Market, By Types |
6.1 France Pyruvate Kinase Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 France Pyruvate Kinase Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 France Pyruvate Kinase Market Revenues & Volume, By Pyrukynd (Mitapivat), 2021- 2031F |
6.1.4 France Pyruvate Kinase Market Revenues & Volume, By RPL301, 2021- 2031F |
7 France Pyruvate Kinase Market Import-Export Trade Statistics |
7.1 France Pyruvate Kinase Market Export to Major Countries |
7.2 France Pyruvate Kinase Market Imports from Major Countries |
8 France Pyruvate Kinase Market Key Performance Indicators |
8.1 Adoption rate of new pyruvate kinase testing technologies in France |
8.2 Number of research studies or clinical trials focused on pyruvate kinase disorders in France |
8.3 Percentage increase in public and private investments in pyruvate kinase research and development in France |
9 France Pyruvate Kinase Market - Opportunity Assessment |
9.1 France Pyruvate Kinase Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 France Pyruvate Kinase Market - Competitive Landscape |
10.1 France Pyruvate Kinase Market Revenue Share, By Companies, 2024 |
10.2 France Pyruvate Kinase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |